Indiana University School of Medicine Awarded Prestigious $2.1 Million Grant To Study Traumatic Brain Injury Post author:Sam Post published:October 1, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017 These 3 Biotechs Could Have the Most Exciting Late-Stage Cancer Candidates August 21, 2017 Tauriga Secures Investment Of $80,000 USD Through A 5% Promissory Note With Fixed Conversion Price Of $0.00125 Per Share June 29, 2017
Janssen R&D Release: Data At ASCO Show Consistent Progression-Free Survival Benefit In Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients Treated With Ibrutinib, Including Those With High-Risk Disease, With Up To Four Years Of Follow-Up June 4, 2017
Tauriga Secures Investment Of $80,000 USD Through A 5% Promissory Note With Fixed Conversion Price Of $0.00125 Per Share June 29, 2017